On January 5, 2024 MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA" or the "Company"), a clinical-stage biopharmaceutical company developing telomere-targeting immunotherapies for cancer, reported its participation in the Biotech Showcase 2024 investor conference being held January 8-10, 2024, in San Francisco, California (Press release, MAIA Biotechnology, JAN 5, 2024, View Source [SID1234639030]). Chairman and Chief Executive Officer Vlad Vitoc, MD, MBA will present on Tuesday, January 9, 2024, at 11:30 am PST.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Vitoc will provide an update on the Company’s lead program, THIO, a potential first-in-class telomere targeting agent in clinical development for the treatment of non-small cell lung cancer (NSCLC). Exceptional preliminary efficacy data from the ongoing THIO-101 Phase 2 trial includes an unprecedented disease control rate (DCR) of 100% in second-line NSCLC treatment. Dr. Vitoc will also discuss multiple value-driving Company milestones expected in 2024 and beyond.
Conference details:
MAIA live presentation:
11:30 am PST, Tuesday, January 9, 2024
Location:
Hilton San Francisco Union Square
Registration:
Available on the conference website.
1-on-1 meetings:
Requests available upon registration.
Presentation slides:
ir.maiabiotech.com under Company Info: Presentations
"We are delighted that MAIA Biotechnology will be joining us in San Francisco and presenting at Biotech Showcase this year," said Sara Demy, CEO of Demy-Colton, producer for the event. "Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery."
The Biotech Showcase investor conference focuses on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors. The conference takes place each year in San Francisco alongside the J.P. Morgan Annual Healthcare Conference.